niacinlovastatin trade names advicor drug combination used treatment dyslipidemia combination lipidmodifying drugvitamin niacin extended release form statin drug lovastatin trade name mevacor combination preparation developed kos pharmaceuticals inc acquired abbott laboratories subsequently transferred abbvie inc company spun abbott january advicor approved us food drug administration fda december fda withdrew approval april reason given based collective evidence several large cardiovascular outcome trials refs agency concluded totality scientific evidence longer supports conclusion druginduced reduction triglyceride levels andor increase hdlcholesterol levels statintreated patients results reduction risk cardiovascular events abbvie inc agreed voluntarily discontinue marketing fda action also applied simcor niacinextended release combination combination available tablets containing niacinlovastatin httpsenwikipediaorgwikiniacinlovastatin